OraSure Technologies (OSUR) Announces Proposed 8M Share Common Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to OraSure Technologies (OSUR) Announces Proposed 8M Share Common Offering
June 3, 2020 5:56 AM EDT
(Updated - June 3, 2020 5:56 AM EDT)
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced the pricing of an underwritten offering of 8,000,000 shares of its common stock at a price of $11.00 per share. After the underwriting discount and estimated offering expenses, OraSure expects to receive net proceeds... More
May 29, 2020 7:00 AM EDT
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a definitive agreement to acquire privately owned UrSure, Inc. (UrSure) for cash.
Based in Boston, UrSure is developing and commercializing products that measure adherence to HIV medications including pre-exposure prophylaxis or PrEP, the daily medication to prevent HIV. This includes laboratory-based tests that can measure levels of the medication in a patients urine or blood, as well as... More
May 29, 2020 6:03 AM EDT
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced the appointment of Lelio Marmora as a member of the Companys Board of Directors effective June 1, 2020. Mr. Marmora, the former executive director of Unitaid, will serve as a Class III Director with an initial term expiring at the Companys 2021 Annual Meeting of Stockholders. He will also serve on the Audit Committee and Nominating and Corporate Governance Committee of the Board.
Lelios comprehensive understanding of the international... More
